#2224 on the rich list of 14,452 insiders
Andrew Paul Mazar
Chief Scientific Officer at Monopar Therapeutics; Chief Operating Officer at Actuate Therapeutics, Inc. Common stock. Based in Fort Worth, Texas.
$60.5M
in disclosed stock, −$400K (−0.66%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 2224th of 14,452
- Companies held
- 2
- Largest holding
- MNPR, 100.0% of total
- Latest SEC filing
- Aug 12, 2024
What the $60.5M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Monopar Therapeutics MNPR Common Stock | Through TacticGem LLC | 822,255 split-adjusted | $70.29 | $57.8M | 95.6% | Form 4, Mar 31, 2022 |
| Monopar Therapeutics MNPR Common Stock | Through Tactic Pharma LLC | 33,333 split-adjusted | $70.29 | $2.3M | 3.9% | Form 4, Mar 31, 2022 |
| Monopar Therapeutics MNPR Common Stock | Directly | 4,425 split-adjusted | $70.29 | $311K | 0.5% | Form 4, Mar 31, 2022 |
| Actuate Therapeutics, Inc. Common stock ACTU Common Stock | Directly | 127,250 | $0.21 | $27K | 0.0% | Form 3, Aug 12, 2024 |
Share counts are the amounts Andrew Paul Mazar reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 2221 | Jonathan Hirt Hagen Director, Erie Indemnity. Philadelphia, PA | $60.5M |
| 2222 | Patrick J. Healy Director, Medline. San Francisco, CA | $60.5M |
| 2223 | Brian Harris Chief Executive Officer, Ladder Capital. New York, NY | $60.5M |
| 2224 | Andrew Paul Mazar Chief Scientific Officer, Monopar Therapeutics. Fort Worth, TX | $60.5M |
| 2225 | Robert M. Friedland Executive Chairman, Ivanhoe Electric. Tempe, AZ | $60.4M |
| 2226 | Arthur G. Sulzberger Chairman and Publisher, The New York Times. New York, NY | $60.3M |
| 2227 | Thomas M. Wojcik President and COO, Affiliated Managers Group. West Palm Beach, FL | $60.3M |
Other Monopar Therapeutics insiders
All MNPR insiders- Diane Hendricks$46.5M10% owner. #2676 overall
- Michael J. Brown$19.1MInsider. #1107 overall
- Chandler Robinson$11.7MChief Executive Officer. #7793 overall
Questions
How much stock does Andrew Paul Mazar own?
Andrew Paul Mazar holds $60,477,515 in listed stock based on SEC filings and current prices, mostly Monopar Therapeutics (MNPR). That ranks 2224th on the Stock Rich List.
Is this Andrew Paul Mazar's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.